Urology · Lake Success, NY
NPI
1457467086
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
450 Lakeville Road, Suite M41, Smith Institute for Urology
Lake Success, NY, 11042
Phone (516) 734-8597
Groups this clinician bills Medicare through
Medicare paid, 2024
$164K
1,821 services
Medicare patients, 2024
584
Average age 74
Drug cost, 2024
$203K
1,513 prescriptions
Company payments, 2025
$136
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David M Hoenig was code 99214 (office e&m - established), 325 times for 251 patients. In total David M Hoenig billed 1,821 services in 69 codes, and Medicare paid $164K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-09-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 325 | 251 | $109.74 | $36K |
| 99213 Office E&M - Established | Office | 249 | 214 | $76.10 | $19K |
| 76770 Ultrasound - Abdomen and Pelvis | Facility | 242 | 201 | $27.95 | $6,764 |
| 99442 Telephone Services | Office | 144 | 114 | $82.00 | $12K |
| 51798 Ultrasound - Nonspecific | Office | 85 | 65 | $10.03 | $852 |
| 99441 Telephone Services | Office | 71 | 64 | $51.05 | $3,625 |
| 99204 Office E&M - New | Office | 60 | 60 | $135.93 | $8,156 |
| 74420 Standard X-ray | Facility | 56 | 48 | $21.52 | $1,205 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 45 | 38 | $96.18 | $4,328 |
| 51700 Other Organ Systems | Facility | 39 | 11 | $27.91 | $1,088 |
| 52000 Cystourethroscopy | Facility | 38 | 29 | $61.02 | $2,319 |
| 99443 Telephone Services | Office | 34 | 33 | $111.24 | $3,782 |
| 52356 Calculus Removal - Urinary | Facility | 32 | 31 | $434.14 | $14K |
| 50435 Other Organ Systems | Facility | 31 | 11 | $92.53 | $2,868 |
| 99232 Hospital E&M - Subsequent | Facility | 22 | 14 | $70.78 | $1,557 |
By year: 2022 $175K for 1,869 services; 2023 $156K for 1,760 services; 2024 $164K for 1,821 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 17 | 17 | $2.23 | $37.87 |
Medicare prescription drug claims, 2024
In 2024, the drug David M Hoenig prescribed most often to Medicare patients was Tamsulosin Hcl, with 324 prescriptions and refills. In total David M Hoenig wrote 1,513 Medicare prescriptions that cost $203K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 324 | 863 | 109 | $5,181 |
| Potassium Citrate Er Potassium Citrate | 307 | 773 | 100 | $44K |
| Finasteride Generic | 239 | 669 | 79 | $3,083 |
| Methenamine Hippurate Generic | 88 | 228 | 36 | $11K |
| Hydrochlorothiazide Generic | 75 | 225 | 25 | $251 |
| Allopurinol Generic | 56 | 156 | 16 | $605 |
| Estradiol Generic | 47 | 109 | 34 | $4,139 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 43 | 123 | 19 | $1,358 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 31 | 32 | 25 | $269 |
| Myrbetriq Mirabegron | 30 | 78 | 11 | $34K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 29 | 30 | 26 | $121 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 27 | 38 | 22 | $485 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 26 | 54 | Under 11 | $432 |
| Chlorthalidone Generic | 21 | 63 | Under 11 | $443 |
| Cefuroxime Cefuroxime Axetil | 19 | 19 | 12 | $166 |
Brand drugs: 168 claims; generic drugs: 1,345 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David M Hoenig $136 ($136 in general payments such as food, travel and fees) from 1 company. The largest payer was Calyxo, Inc. with $136.
| Company | Payments | Amount |
|---|---|---|
| Calyxo, Inc. | 1 | $136 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.